A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery
Researchers at Cold Spring Harbor Laboratory (CSHL) today report the discovery of a novel cellular biomarker that could make it comparatively easy for cancer surgeons to determine if a patient has a potentially lethal mutation ...
Jan 5, 2015